Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Income from Continuing Operations (2020 - 2025)

BioAtla (BCAB) has disclosed Income from Continuing Operations for 6 consecutive years, with 9182000.0 as the latest value for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 41.48% year-over-year to 9182000.0; the TTM value through Dec 2025 reached 58466000.0, up 17.16%, while the annual FY2025 figure was 58462000.0, 17.16% up from the prior year.
  • Income from Continuing Operations hit 9182000.0 in Q4 2025 for BioAtla, up from 13656000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 9182000.0 in Q4 2025 and bottomed at 35741000.0 in Q2 2023.
  • Average Income from Continuing Operations over 5 years is 22750000.0, with a median of 23505500.0 recorded in 2021.
  • Year-over-year, Income from Continuing Operations crashed 1508.0% in 2021 and then skyrocketed 68.22% in 2024.
  • BioAtla's Income from Continuing Operations stood at 23392000.0 in 2021, then decreased by 17.62% to 27513000.0 in 2022, then rose by 2.24% to 26898000.0 in 2023, then soared by 41.67% to 15690000.0 in 2024, then surged by 41.48% to 9182000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 9182000.0, 13656000.0, and 18414000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.